One dose of synthetic psilocybin in combination with psychotherapy significantly reduces treatment-resistant depression associated with bipolar II disorder (BDII), a small, nonrandomized clinical ...
Synthetic psilocybin with psychotherapy was effective and safe for patients with treatment-resistant bipolar depression, a small nonrandomized controlled trial suggested. Among 15 people with bipolar ...
Having bipolar disorder -- a serious mental illness that can cause both manic and depressed moods -- can make life more challenging. It also comes with a higher risk of dying early. Now, a study puts ...
It is well-proven that cannabis use is associated with an increased risk of schizophrenia and heavy use of high-THC marijuana is associated with four times the normal rate of schizophrenia (see my ...
Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...
A recent Nutrients journal study reviews the potential beneficial effects of the ketogenic diet (KD) on anxiety, depression, stress, schizophrenia, and bipolar disorder. Study: The Potential Effects ...
Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...
INDIANAPOLIS — After 15 years of careful research and study spent working with more than 1,000 patients with mental health issues, a team of researchers at IU School of Medicine have created a blood ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results